Clinical and cytological characteristics in people with nodular thyroid disease
Keywords:
BIOPSY NEEDLE, GOITER NODULAR, THYROID NEOPLASMS, THYROID NODULE, THYROIDAbstract
Introduction: nodular thyroid disease has increased its prevalence in recent years. The cytological study is the cornerstone for decision making in the management of this entity and offers the best predictive value in the pre-surgical assessment.
Objective: to describe clinical and cytological characteristics of patients with nodular thyroid disease who underwent fine needle aspiration biopsy (FNAB).
Methods: a descriptive, cross-sectional study comprising the period from January to December of 2016. The target group included 873 people who underwent thyroid FNAB at Abel Santamaría Cuadrado General Teaching Hospital. The cytology records of the Department of P Anatomy were reviewed, collecting the data of all the patients who performed this procedure and the ultrasonographic reports. The variables studied were age, sex, size of the nodule, cytological diagnosis. The data were processed using Microsoft Excel. Frequency distribution tables were made.
Results: 90.4 % of the sample corresponded to female gender; 26.6% belonged to the age group between 40 and 49 years, 83.2 % had a nodule between 1 and 1.9cm; 0.9 % of the nodules were diagnosed as malignant.
Conclusions: female gender predominated and the age group between 40 and 49 years, the most frequent cytological diagnosis was benign. Thyroid malignancy increased with age.
Downloads
References
1. Bustillo Madrigal E, Bustillo Solano E, Denis Cancio H. Prevalencia y caracterización de la enfermedad tiroidea nodular y del bocio difuso en un área urbana. Rev Cubana Endocrinol [en línea]. 2014 Ago [consulta: 30 Mar 2017]; 25(2): 87–103. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532014000200006&lng=pt&tlng=es
2. Maia FFR, Matos PS, Silva BP, Pallone AT, Pavin EJ, Vassallo J, et al. Role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid nodule. Head Neck Oncol [En línea]. 2011 Jan [consulta: 19 Feb 2018]; 3: 17. Disponible en: https://headandneckoncology.biomedcentral.com/articles/10.1186/1758-3284-3-17
3. Pereira Despaigne OL, Rodríguez Fernández Z, Dorimain Pierre C, Falcón Vilariño GC, Ochoa Marén G. Diagnóstico de las afecciones nodulares del tiroides. MEDISAN [En línea]. 2015 Jun [consulta: 25 Nov 2015]; 19(6): 788-96. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192015000600012&lng=es
4. Hurtado López LM, Basurto Kuba E, Montes de Oca Durán ER, Pulido Cejudo A, Vázquez Ortega R, Athié Gutiérrez C. Prevalencia de nódulo tiroideo en el valle de México. RevCir Cir [En línea]. 2011 Mar-Abr [consulta: 19 Feb 2018]; 79(2): 114-17. Disponible en: http://www.medigraphic.com/pdfs/circir/cc-2011/cc112c.pdf
5. Turcios Tristá SE, Infante Amorós A, González Rivero L. Nódulo de tiroides. Rev Cubana Endocrinol [En línea]. 2012 [consulta: 30 Mar 2017]; 23(3):234–41.Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532012000300008&lng=pt&tlng.=es
6. Navarro Despaigne D. Epidemiología de las enfermedades del tiroides en Cuba. Rev Cubana Endocrinol [En línea]. Abr 2004 [consulta: 25 Nov 2015]; 15(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532004000100004
7. Cibas E, Ali S. The Bethesda system for reporting thyroid cytopathology. AJCP [En línea]. 2009 [consulta: 19 Feb 2018]; 132(5): 658-6. Disponible en: https://academic.oup.com/ajcp/article/132/5/658/1765741
8. Navarro Despaigne DA. Hormonas tiroideas en afecciones benignas y malignas del tiroides, de la certidumbre a la duda. Rev Cubana Endocrinol [En línea]. 2015 [consulta: 30 Mar 2017]; 26(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532015000300006
9. Rojo Quintero N, Suárez Sori BG, Rondón Martínez E, DurruthyWillsom O, Valladares Lorenzo R. Enfermedad nodular de tiroides, incidencia y correlación citohistológica. AMC [En línea]. 2016 May-Jun [consulta: 30 Mar 2017]; 20(3): 299-308. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-02552016000300010
10. Pistelli A, Foddis R, Guglielmi G, Bonotti A, Cristaudo A. Prevalence of thyroid disease in healthcare workers occupationally exposed to ionizing radiation at the University Hospital of Pisa. G Ital Med Lav Ergon [En línea]. 2012 [consulta: 19 Feb 2018]; 34(Suppl-3): 280-2.Disponible en: http://europepmc.org/abstract/med/23405642
11. Gharib M, Gharib H. Guidelines for the diagnosis and management of thyroid nodules. Thyroid International [En línea]. 2011 [consulta: 19 Feb 2018]; 21(10): 3-11.Disponible en: https://www.liebertpub.com/doi/pdfplus/10.1089/thy.2011.0087
12. Galofré JC. Guía clínica para el manejo del nódulo tiroideo y cáncer de tiroides duranteel embarazo. EndocrinolNutr [En línea]. 2014 Mar [consulta: 19 Feb 2018]; 61(3): 130-8. Disponible en: http://www.elsevier.es/es-revista-endocrinologia-nutricion-12-articulo-guia-clinica-el-manejo-del-S1575092213002714
13. Schönberger J, Marienhagen J, Agha A. Papillary microcarcinoma and papillary cancer of the thyroid-1 cm: modified definition of the WHO and the therapeutic dilemma. Nuklearmedizin [En línea]. 2007 [consulta: 19 Feb 2018]; 46: 115-20. Disponible en: https://www.thieme-connect.com/products/ejournals/abstract/10.1160/nukmed-0059
14. Valenciaga Rodríguez JL, Galán Álvarez Y, Turcios Tristá SE, Piña Rivera Y, Navarro Despaigne D, Barroso López O. Cáncer de tiroides en Cuba: estudio de 14 años. Rev Cubana Endocrinol [En línea]. 2005 Sep-Dic [consulta: 19 Feb 2018]; 16(3): 32-45. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532005000300002
15. Brito Sosa G, Guerra Mesa JL, Cassola Santana JR. Cáncer diferenciado de tiroides y tiroiditis de Hashimoto en el Instituto Nacional de Oncología y Radiobiología (2006 - 2010). Rev Cubana Cir [En línea]. 2015 Sep [consulta: 25 Nov2015]; 54(3). Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S0034-74932015000300002&lng=es
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/
